219 related articles for article (PubMed ID: 31830238)
1. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.
Shields CL; Dalvin LA; Chang M; Mazloumi M; Fortin P; McGarrey M; Martin A; Yaghy A; Yang X; Vichitvejpaisal P; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2020 Feb; 138(2):136-146. PubMed ID: 31830238
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
4. Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients.
Yang X; Dalvin LA; Mazloumi M; Chang M; Shields JA; Mashayekhi A; Shields CL
Clin Exp Ophthalmol; 2020 Jul; 48(5):610-623. PubMed ID: 32277560
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
Dalvin LA; Zhang Q; Hamershock RA; Chang M; Yu MD; Mashayekhi A; Shields CL
Br J Ophthalmol; 2020 May; 104(5):697-702. PubMed ID: 31409650
[TBL] [Abstract][Full Text] [Related]
6. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO STEREOTACTIC RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA.
Koc I; Kadayifcilar S; Kiratli H; Eldem B
Retin Cases Brief Rep; 2019; 13(4):352-356. PubMed ID: 28489707
[TBL] [Abstract][Full Text] [Related]
11. RETINAL MICROVASCULAR CHANGES IN UVEAL MELANOMA FOLLOWING CONBERCEPT INJECTION AFTER PLAQUE RADIOTHERAPY AS DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Yang JY; Wang Q; Chen MX; Yan YN; Zhou WJ; Liu YM; Wei WB
Retina; 2021 Dec; 41(12):2605-2611. PubMed ID: 34155168
[TBL] [Abstract][Full Text] [Related]
12. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
13. Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
Horgan N; Shields CL; Mashayekhi A; Salazar PF; Materin MA; O'Regan M; Shields JA
Ophthalmology; 2009 Jul; 116(7):1383-90. PubMed ID: 19481812
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
16. PARAFOVEAL CAPILLARY DENSITY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA: Analysis of Eyes Without Radiation Maculopathy.
Say EA; Samara WA; Khoo CT; Magrath GN; Sharma P; Ferenczy S; Shields CL
Retina; 2016 Sep; 36(9):1670-8. PubMed ID: 27232466
[TBL] [Abstract][Full Text] [Related]
17. Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
Schefler AC; Fuller D; Anand R; Fuller T; Moore C; Munoz J; Kim RS;
Am J Ophthalmol; 2020 Aug; 216():165-173. PubMed ID: 32278771
[TBL] [Abstract][Full Text] [Related]
18. Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma.
Shah SM; Tanke LB; Deufel CL; Petersen IA; Corbin KS; Hodge DO; Olsen TW; Dalvin LA
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1305-1320. PubMed ID: 37950755
[TBL] [Abstract][Full Text] [Related]
19. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
[TBL] [Abstract][Full Text] [Related]
20. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
